Drug discovery targeted at transthyretin cardiac amyloidosis: rational design, synthesis, and biological activity of new transthyretin amyloid inhibitors

Amyloid. 2011 Jun;18 Suppl 1:55-7. doi: 10.3109/13506129.2011.574354019.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amyloid / antagonists & inhibitors*
  • Amyloidosis / drug therapy*
  • Amyloidosis / metabolism
  • Drug Discovery*
  • Heart Diseases / drug therapy*
  • Heart Diseases / metabolism
  • Humans
  • Prealbumin / antagonists & inhibitors*

Substances

  • Amyloid
  • Prealbumin